More effective & durable treatments for cancer and immunological diseases

We aim to develop medicines that can positively transform patient lives

Stamford Pharmaceuticals Inc clinical trials

News & Events

Our Approach

Cancers are complex dynamic and adaptive diseases with the tumor micro-environment comprising many different cell types, matrix proteins and secreted molecules.  The  interplay between these elements forms a redundant regulatory network that enables continued tumor survival, adaptation and progression even in the face of potent treatments.  There is increasing evidence that single-target drugs do not provide durable outcomes for many patients.   We believe that taking a multi-target approach offers an opportunity to improving response rates and durability by maximizing synergistic efficacy while reducing off-target toxicities.

Pipeline: SP-002 Monotherapy and Combination Compositions

Pipeline Portfolio

Our Disease Focus

Basal cell carcinoma

Basal Cell Carcinoma

Squamous cell carcinoma

Cutaneous Squamous Cell Carcinoma

Breast cancer

Cutaneous Breast Cancer